All In MedTech

FDA Clearance Tracker · P100045-S056

CardioMEMs HF System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 18, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 18, 2022

Approved

Time to decision

232 days

Received Jul 1, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P100045-S056
Device name
CardioMEMs HF System
Applicant location
Atlanta, GA
Received
Jul 1, 2021
Decided
Feb 18, 2022
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P100045

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MOM

FDA's approval statement

As written in FDA's record.

Approval for the CardioMEMS HF System. The device is indicated for wirelessly measuring and monitoring pulmonary artery pressure and heart rate in NYHA Class II or III heart failure patients who either have been hospitalized for heart failure in the previous year and/or have elevated natriuretic peptides. The hemodynamic data are used by physicians for heart failure management with the goal of controlling pulmonary artery pressures and reducing heart failure hospitalizations.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.